title: Thalidomide therapy induces response in relapsed mantle cell lymphoma.
authors.forename: G
authors.initials: G
authors.lastname: Damaj
authors.forename: F
authors.initials: F
authors.lastname: Lefrère
authors.forename: R
authors.initials: R
authors.lastname: Delarue
authors.forename: B
authors.initials: B
authors.lastname: Varet
authors.forename: R
authors.initials: R
authors.lastname: Furman
authors.forename: O
authors.initials: O
authors.lastname: Hermine
mesh_terms: D000368:Aged; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D019008:Drug Resistance, Neoplasm; D006801:Humans; D020522:Lymphoma, Mantle-Cell / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy; D016879:Salvage Therapy; D013792:Thalidomide / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D020533:Angiogenesis Inhibitors; D013792:Thalidomide